•
Mar 31, 2024

Sabra Health Care REIT Q1 2024 Earnings Report

Sabra's portfolio continued to grow stronger with improvements in coverage, occupancy, and NOI. The balance sheet remained strong and poised to support future growth.

Key Takeaways

Sabra Health Care REIT reported first quarter 2024 results, with net income of $0.11 per diluted common share, FFO of $0.32, Normalized FFO of $0.34, AFFO of $0.35, and Normalized AFFO of $0.35. The company reiterated its 2024 earnings guidance. Sabra's portfolio continues to grow stronger, with improvements in coverage, occupancy, and NOI.

Net Income: $0.11 per diluted common share

FFO: $0.32 per share

Normalized FFO: $0.34 per share

AFFO: $0.35 per share

Total Revenue
$172M
Previous year: $161M
+6.7%
EPS
$0.35
Previous year: $0.34
+2.9%
FFO per diluted share
$0.32
Previous year: $0.32
+0.0%
Normalized FFO per diluted share
$0.34
Previous year: $0.33
+3.0%
AFFO per diluted share
$0.35
Previous year: $0.33
+6.1%
Gross Profit
$75.3M
Previous year: $114M
-33.7%
Cash and Equivalents
$59.9M
Previous year: $33.5M
+78.7%
Free Cash Flow
$52.8M
Total Assets
$5.37B
Previous year: $5.56B
-3.3%

Sabra Health Care REIT

Sabra Health Care REIT

Sabra Health Care REIT Revenue by Segment

Forward Guidance

Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): •Net Income: $0.53 - $0.57 •FFO: $1.33 - $1.37 •Normalized FFO: $1.34 - $1.38 •AFFO: $1.38 - $1.42 •Normalized AFFO: $1.39 - $1.43 Earnings guidance above assumes no 2024 acquisition or disposition activity.

Revenue & Expenses

Visualization of income flow from segment revenue to net income